
Sanofi: agreement signed with CD&R on Opella
(CercleFinance.com) - Having finalised the information and consultation process with the relevant employee representative bodies, Sanofi reports that it has signed the share purchase agreement that will enable CD&R to acquire a controlling 50% stake in Opella.
The healthcare group says that Bpifrance is expected to participate as a minority shareholder with a stake of around 2% in Opella, and that Sanofi will remain a significant shareholder in this consumer healthcare company.
The terms of the previously announced transaction remain unchanged, and completion is expected in Q2 2025 at the earliest. It remains subject to receipt of the usual regulatory approvals from the relevant authorities.
Copyright (c) 2025 CercleFinance.com. All rights reserved.
The healthcare group says that Bpifrance is expected to participate as a minority shareholder with a stake of around 2% in Opella, and that Sanofi will remain a significant shareholder in this consumer healthcare company.
The terms of the previously announced transaction remain unchanged, and completion is expected in Q2 2025 at the earliest. It remains subject to receipt of the usual regulatory approvals from the relevant authorities.
Copyright (c) 2025 CercleFinance.com. All rights reserved.